Corrigendum: Scopoletin Suppresses Activation of Dendritic Cells and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling
- National Engineering Laboratory for Resource Development of Endangered Crude Drugs in Northwest China, The Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry, The Ministry of Education, College of Life Sciences, Shaanxi Normal University, Xi’an, China
by Zhang F, Zhang Y, Yang T, Ye Z-Q, Tian J, Fang H-R, Han J-J, Wang Z-Z and Li X (2019). Front. Pharmacol.10:863. doi: 10.3389/fphar.2019.00863
In the published article, author Zhe-Zhi Wang’s identity was incorrect. Instead of “co-author,” it should be “co-corresponding author.” The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Keywords: scopoletin, experimental autoimmune encephalomyelitis, multiple sclerosis, dendritic cells, NF-κB signaling
Citation: Zhang F, Zhang Y, Yang T, Ye Z-Q, Tian J, Fang H-R, Han J-J, Wang Z-Z and Li X (2019) Corrigendum: Scopoletin Suppresses Activation of Dendritic Cells and Pathogenesis of Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling. Front. Pharmacol. 10:1037. doi: 10.3389/fphar.2019.01037
Received: 13 August 2019; Accepted: 14 August 2019;
Published: 13 September 2019.
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
Copyright © 2019 Zhang, Zhang, Yang, Ye, Tian, Fang, Han, Wang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
†These authors have contributed equally to this work